183 related articles for article (PubMed ID: 21282034)
1. [Cardiac biomarkers in perioperative risk stratification].
Fellahi JL; Piriou V; Longrois D
Ann Fr Anesth Reanim; 2011 Feb; 30(2):126-40. PubMed ID: 21282034
[TBL] [Abstract][Full Text] [Related]
2. [Cardiac biomarkers and pulmonary embolism: prognostic stratification].
Blaudszun G; Vuilleumier N; Righini M; Louis-Simonet M
Rev Med Suisse; 2009 Oct; 5(221):2022-4, 2026-7. PubMed ID: 19911687
[TBL] [Abstract][Full Text] [Related]
3. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
[TBL] [Abstract][Full Text] [Related]
4. B type natriuretic peptide--a diagnostic breakthrough in peri-operative cardiac risk assessment?
Rodseth RN
Anaesthesia; 2009 Feb; 64(2):165-78. PubMed ID: 19143695
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in advanced heart failure: diagnostic and therapeutic insights.
Nagarajan V; Tang WH
Congest Heart Fail; 2011; 17(4):169-74. PubMed ID: 21790966
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of biomarkers in cardiac failure].
Paredes C A; Vega J; de León A; Kanacri A; Castro P; Baeza R
Rev Med Chil; 2013 Dec; 141(12):1560-9. PubMed ID: 24728434
[TBL] [Abstract][Full Text] [Related]
7. Role of biomarkers in chemotherapy-induced cardiotoxicity.
Cardinale D; Sandri MT
Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
[TBL] [Abstract][Full Text] [Related]
8. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
9. Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting.
Biccard BM; Devereaux PJ; Rodseth RN
Anaesthesia; 2014 May; 69(5):484-93. PubMed ID: 24738805
[TBL] [Abstract][Full Text] [Related]
10. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
Palazzuoli A; Iovine F; Gallotta M; Nuti R
Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in acute cardiac disease: the present and the future.
Jaffe AS; Babuin L; Apple FS
J Am Coll Cardiol; 2006 Jul; 48(1):1-11. PubMed ID: 16814641
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery.
Fellahi JL; Hanouz JL; Le Manach Y; Gué X; Monier E; Guillou L; Riou B
Anesthesiology; 2009 Aug; 111(2):250-7. PubMed ID: 19568166
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
[TBL] [Abstract][Full Text] [Related]
14. [Redefinition of myocardial infarction--relevance of biomarkers].
Weber M; Hamm C
Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
[TBL] [Abstract][Full Text] [Related]
15. [Role of biomarkers for risk stratification in the prevention of cardiovascular diseases].
Sinning C; Keller T; Blankenberg S
Dtsch Med Wochenschr; 2009 Oct; 134(40):2019-22. PubMed ID: 19777420
[No Abstract] [Full Text] [Related]
16. Cardiac biomarkers: a contemporary status report.
Maisel AS; Bhalla V; Braunwald E
Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):24-34. PubMed ID: 16391615
[TBL] [Abstract][Full Text] [Related]
17. Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process.
Perna ER; Címbaro Canella JP; Macin SM
Minerva Cardioangiol; 2005 Dec; 53(6):523-35. PubMed ID: 16333236
[TBL] [Abstract][Full Text] [Related]
18. Impact of elevated cardiac biomarkers on mortality after vascular surgery procedures.
Buckley R; Stevens SL
Semin Vasc Surg; 2014 Dec; 27(3-4):152-5. PubMed ID: 26073824
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Bertomeu V; Pellicer M; Chorro FJ
Int J Cardiol; 2005 Feb; 98(2):277-83. PubMed ID: 15686779
[TBL] [Abstract][Full Text] [Related]
20. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
